Todd E. Williams, M.D
Doctor of Medicine
Todd E. Williams, M.D. has special interests in lung, head/neck and esophageal cancers. Dr. Williams has been an invited reviewer for many peer-reviewed journals and has published nine articles and five abstracts or manuscripts in peer-reviewed journals.
Dr. Williams received his B.S. in chemical engineering from the University of South Carolina and his M.D. from MUSC in Charleston, S.C.
Dr. Williams performed his general surgery internship and radiation oncology residency at MUSC. Dr. Williams is licensed in South Carolina and board-certified in radiation oncology by the American Board of Radiology.
Before joining Carolina Regional Cancer Center, Dr. Williams was an assistant professor of radiation oncology at MUSC. During his tenure at MUSC, Dr. Williams was involved in research on such esoteric subjects as the development of an iso-effect equation between low-dose rate I-125 brachytherapy and acute, fractionated radiotherapy, taking into account both intratherapy cellular proliferation and division delay.
At MUSC, Dr. Williams was the principal investigator on a number of leading-edge studies related to optimum radiation doses, reducing toxicity and increasing effectiveness of radiation therapy on lung and head/neck cancer patients. Dr. Williams was also a National Cancer Institute investigator on a study related to esophageal cancer patients. He remains a clinical assistant professor in radiation oncology at MUSC.
Curriculum Vitae:
Work Address:
Carolina Regional Cancer Center
4708 Oleander Drive
Myrtle Beach, SC 29577
Education:
Medical University of South Carolina
Charleston, South Carolina
M.D., 1983-1987
University of South Carolina
Columbia, South Carolina
B.S. Chemical Engineering, 1979-1983
Postgraduate Training:
Internship - General Surgery
Medical University of South Carolina
Charleston, South Carolina
1987-1988
Residency - Radiation Oncology
Medical University of South Carolina
Charleston, South Carolina
Completed January 1992
American Board of Radiology Certified in Radiation Oncology,
June 9, 1994
Active Licensure:
South Carolina, Medical License
North Carolina, Medical License
DEA License
DHEC License
Academic and Professional Appointments:
Assistant Professor of Radiation Oncology
Medical University of South Carolina
July 1997 – December 2000
Instructor of Radiation Oncology
Medical University of South Carolina
January 1992 - July 1997
Medical Practice
Experience:
Staff Physician
Rivers Avenue Urgent Care Center
Charleston, South Carolina
1988 - 1989
Teaching Experience:
Active participation in the training of radiation oncology residents,
including regular clinical lectures
1992 – December 2000
Participating in testing MUSC parallel curriculum medical students
1996 - December 2000 Physical diagnosis instruction for MUSC medical students
1996
Basic Research Experience:
Medical University of South Carolina
Radiation Oncology, Division of Radiobiology
Subject: development of isoeffect equation between low-dose rate I-125 brachytherapy and acute fractionated radiotherapy, taking into account both intratherapy proliferation and division delay.
1988 - 1989
Clinical Research
Activities:
Radiation Therapy Oncology Group (RTOG)
Principal Investigator for Medical University of South Carolina
Co-Investigator of MUSC SORTIE Trial
(Multi-Institutional Phase II Trial of Stent or Radiation Therapy Intervention for Esophageal Cancer Dysphagia)
Began Accrual February 1998 - Closed Spring 2000
Principal Investigator for MUSC 7498
(Phase I/II Radiation Dose Escalation Trial for Stage I, II, and III Non-Small Cell Lung Cancer Patients.)
Began Accrual February 1998
Principal Investigator for MUSC for British Biotech Protocol C03/IVB/173
(Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Marimastat in Patients with Minimal Disease, Stage II Non-Small Cell Lung Cancer.)
Principal Investigator for MUSC
(Phase III Trial of Hylarad in Patients Undergoing Radiotherapy for Head and Neck cancer.)
Accrual began August 2000
Principal Investigator for MUSC
(Phase III Trial of Ethyol in Patients Undergoing Combined Radiotherapy and Chemotherapy with Esophageal Cancer.)
Accrual began August 2000
National Cancer Institute Investigator No. 26414
Grants: $48,000 for Marimastat in patients with minimal disease, Stage III, Non-Small Cell Lung Cancer (C03/IVB/173) from British Biotech, Inc.
$82,600 for Hylarad in Patients Undergoing Radiotherapy for Head and Neck Cancer from Biomatrix, Inc.
$100,000 for Ethyol in Patients Undergoing Radiotherapy and Chemotherapy for Esophageal Cancer from Alza Pharmaceuticals, Inc.
Memberships in Professional Organizations:
American Medical Association
South Carolina Medical Association
American Society for Therapeutic Radiology and Oncology
South Carolina Cancer Pain Initiative
American Society of Clinical Oncology
American College of Radiation Oncology
Committees: Chairman, Hollings Cancer Center
Clinical Research Committee
Charleston, South Carolina
1998 - 2000
Medical University of South Carolina
Institutional Review Board
Charleston, South Carolina
1997 - 2000
Committee on Residency Training on Radiation Oncology Commission on Education
American College of Radiology
1999 - 2000
Medical University of South Carolina
Radiation Safety Committee
Charleston, South Carolina
1995 - 2000
Dissertation Committee
For Ph.D. Candidate in Biometry and Epidemiology
Data Safety Monitoring Committee
for Multi-Institutional Ultraflex Tracheobronchial Stent Quality of Life Study
1999
Hollings Cancer Center
Clinical Trials Data Safety and Monitoring Board
Charleston, South Carolina
2000 Academic Activities:
Invited Reviewer for Journal of Radiation Oncology, Biology, and Physics
Invited Reviewer for Journal of the American Academy of Dermatology
Invited Reviewer for The Oncologist
Contributing Author (Lung Section) and Editor
American College of Radiology
In-service Examination for Radiation Oncology Residents
1999 and 2000
Invited Lectures:
"Combined Chemotherapy and Radiotherapy in Locally Advanced Head and Neck Cancer"
Myrtle Beach Oncology Society
Sponsored by Bristol-Myers Squibb
February 2000
"Radiation Therapy in Cancer Palliation"
Hollings Cancer Center
Medical University of South Carolina
Charleston, South Carolina
November 9, 1999
Guest Speaker
South Carolina Red Cross Hemophoresis Division
Annual Meeting
Columbia, South Carolina
October 1996
Guest Speaker
South Carolina Cancer Pain Initiative
Hilton Head Hospital
Hilton Head, South Carolina
May 1996
Guest Speaker
South Carolina Cancer Pain Initiative
Doctor Home Health
Charleston, South Carolina
August 1996
Professional Interests:
Thoracic Malignancies
Head and Neck Malignancies
877-460-2657 - Toll Free
843-449-9415 - Local
Carolina Regional Cancer Center
4708 Oleander Drive, Myrtle Beach, SC 29577
